Author: manco

The MANCO Consortium is active within the scientific community. Our Partner CSIC has recently participated to major international conferences: the 8th European Congress of Virology (Gdansk, Poland) and the XVIth International Nidovirus Symposium (Montreux, Switzerland). In both events, posters were presented to show the MANCO results in particular in relation with our work performed in

The MANCO consortium has reached an important milestone! The MANCO team has been searching for broadly neutralizing human monoclonal antibodies to treat COVID-19. We identified a broadly reactive SARS-CoV-2 – 87G7 – that potently neutralized Omicron and other variants of concern. Moreover we demonstrated that 87G7 can provide protection against infection with these SARS-CoV-2 variants

The MANCO Consortium gathered for the first annual meeting on 28th January 2021. Once again the meeting was held via videoconference due to the COVID-19 pandemic. The 8 MANCO Partners presented and discussed the progress made per work package over the first year of the project. The project Scientific Officer at the European Commission participated to

The MANCO Project has joined Twitter! In addition to our website, we now have a Twitter account to communicate about our research and engage with project stakeholders as well as any people interested in what we are doing. In order to join the MANCO community and hear about the latest news, please follow us on